Michelle Tianqing Liu

LINKEDIN (opens in a new window) | X (opens in a new window)

PhD, BPharm, MRSC
Vice-Chancellor's Senior Research Fellow - Pharmacologist/Natural Products Chemistry, NICM Health Research Institute

Dr Tianqing (Michelle) Liu joined NICM Health Research Institute in 2020 as Western Sydney University Vice-Chancellor’s Senior Research Fellow, working in pharmacology. She has a long-standing interest in human cancers and neurological disorders, with her current research focus on the use of nanotechnology to overcome medical barriers in disease diagnosis and therapy.

Dr Liu has been recognised for scientific excellence with several grants, fellowships and awards including 2016 NHMRC Peter Doherty-Australian Biomedical Fellowship, 2015 Women in Technology Rising Star Award and as 2019 finalist for L'Oréal-UNESCO For Women in Science Australian & New Zealand Fellowship for her work in developing nanomedicines for disease diagnosis and treatment.

She has a long-standing interest in biology and pathophysiology of human cancers and neurological disorders. Her current research focus is on the use of bio-inspired materials and nanotechnology to generate multifunctional nanostructures to overcome the current medical barriers in disease diagnosis and therapy. Her research is highly productive, leading to 85 original research publications, including 40 fist/last/corresponding author articles, in leading in leading journals such as ACS NANO (IF 18), Nano Letters (IF 12), Biomaterials (IF 15), Journal of Controlled Release (IF 11), Journal of Nanobiotechnology (IF 10) and ACS Applied Materials & Interfaces (IF 10). She has given 36 presentations at national/international conferences, 15 of which were as invited speakers, 1 keynote and 1 plenary. Dr Liu has attracted significant research funding from various competitive funding agencies with a total of over $2 million.

Research focus

Design and synthesis of advanced biomaterials and their applications in cancer therapy and diagnosis, cardiovascular disease prevention and treatment, and neurological disorders treatment.
Mechanisms of iron-related cell death in diseased conditions.
Pathological roles of immune cells exosomes derived from immune cells in cancer and neurological disorders.

Awards and recognitions

2023 Vice-Chancellor's Professional Development Award
2022 Women in Nanobiotechnology, Journal of Nanobiotechnology
2022 School of Science Early Career Research Excellence Award Highly commended
2021Fellow of Advance HE (FHEA)
2020 Vice-Chancellor’s Research Fellowship, Western Sydney University
2020 Journal C Best Paper Award, Journal of Carbon Research
2019 Finalist of L'Oréal-UNESCO For Women in Science Australian and New Zealand Fellowship
2019 Finalist of ASMR Queensland Health and Medical Research Awards (Early Career)
2018 The Bridge Program Best Team Pitch Presentation (selected by Pfizer and Novartis)
2018 The Bridge Program Travel Award
2016 NHMRC Peter Doherty - Australian Biomedical Fellowship
2015 Women in Technology Rising Star Award
2014 Chinese Academy of Science Visiting Fellowship for Overseas
2013 Chinese Government Award for Outstanding Students Studying Abroad

Affiliations

Member, Controlled Release Society
Member, Royal Society of Chemistry
Member, Australian Nanotechnology Network
Member, Australasian Pharmaceutical Science Association
Member, Australian Society for Medical Research
Member, Gastroenterological Society of Australia
Member, Australia Chinese Association for Biomedical Science
Member, Australian Synchrotron
Member, Women in Technology
2021-present Topic Editor and Editorial Board Member, Pharmaceutics
2021-present Young Editorial Board Member, Exploration
2021-present Academic Editor and Editorial Board Member, PLOS ONE
2021-present Reviewer, Advanced Healthcare Materials
2021-present Reviewer, Acta Biomaterialia
2021-present Reviewer, Pharmaceutics
2021-present Reviewer, Journal of Nanobiotechnology
2021-present Reviewer, Cells
2021-present Reviewer, Molecules
2021-present Reviewer, Journal of Drug Delivery Science and Technology
2021-present Reviewer, Frontiers in Pharmacology
2021-present Reviewer, Frontiers in Oncology
2021-present Reviewer, Frontiers in Medical Technology
2020-present Committee Member, Australian Academy of Science: National COVID-19 Expert Database
2020-present Reviewer, ACS Applied Electronic Materials
2019-present Member, Australia-China Pharmaceutical Innovation Network
2019-present Reviewer, ACS Applied Materials and Interfaces
2019-present Reviewer, ACS Sensors
2018-present Executive Committee Chair, Australia-China Pharmaceutical Innovation Network
2018-present Reviewer, Biomaterials
2018-present Reviewer, International Journal of Nanomedicines
2018-present Reviewer, Analyst
2018-present Reviewer, Cellular Signalling
2018-present Reviewer, Evidence-Based Complementary and Alternative Medicine
2017-present Reviewer, Nanoscale
2017-present Reviewer, New Journal of Chemistry
2017-present Reviewer, Molecular Pharmaceutics
2017-present Reviewer, Theranostics
2016-present Reviewer, Toxicology Letters
2016-2018 Committee Member, Australian Society for Medical Research - Queensland
2015-present Reviewer, RSC Advances

Education

2014 PhD (Nanomedicine and Bionanomaterials), University of South Australia, Australia
2007 Bachelor of Pharmacy (Advance Program), Wuhan University, China

Publications

For a full listing of publications please see:

WESTERN SYDNEY UNIVERSITY PROFILE (opens in a new window)
ORCID (opens in a new window)
RESEARCHGATE (opens in a new window)